Manheim Central School Board discusses proposal to add HealthWorks as health insurance option

Manheim Central School Board discusses proposal to add HealthWorks as health insurance option

When: Meeting of the Manheim central school board, October 23. What happened: The board discussed but took no action on a proposal to add Penn Medicine HealthWorks as an optional care provider for employee health insurance. Why is this important: HealthWorks would not replace current health insurance but would be… Continue Reading Manheim Central School Board discusses proposal to add HealthWorks as health insurance option

FDA Approves New Corticosteroid Treatment Option for DMD Patients | BioSpace

FDA Approves New Corticosteroid Treatment Option for DMD Patients |  BioSpace

Pictured: A boy sitting in a wheelchair on a beach/iStock, ChiccoDodiFC The FDA on Thursday approved Santhera Pharmaceuticals’ new corticosteroid vamorolone, now marketed under the brand name Agamree, for the treatment of Duchenne muscular dystrophy. The announcement was made by Florida-based Catalyst Pharmaceuticals, which paid $90 million upfront in June… Continue Reading FDA Approves New Corticosteroid Treatment Option for DMD Patients | BioSpace